Postanalytic Reporting

Turning Verified Results into Safe, Actionable Reports

The postanalytic phase is where microbiology data becomes clinical action, and ASCP tests whether you know what to release, when, and to whom. A core concept is the critical (panic) value -- a result so urgent that CLIA requires the laboratory to alert the requesting clinician immediately; the laboratory's policy sets how the call and read-back are documented.

Microbiology Critical Values

Unlike chemistry numbers, microbiology critical results are qualitative findings that imply life-threatening infection:

• A positive blood culture Gram stain (especially gram-positive cocci in clusters or gram-negative rods).
• A positive CSF Gram stain or any organism in spinal fluid.
• A positive acid-fast (AFB) smear suggesting active tuberculosis (infection-control implications).
• Detection of a bioterrorism/select agent (e.g., Bacillus anthracis, Francisella, Brucella) -- stop work, notify the laboratory director and public health.
• A blood/sterile-site positive for a multidrug-resistant organism per facility policy.

Laboratory policy sets the documentation, usually the date/time, the result, the name of the person notified, and read-back confirmation. A stem describing a positive CSF Gram stain that was simply filed in the chart without a call is a postanalytic failure -- the best answer is immediate telephone notification with documentation.

Preliminary vs. Final Reports

Microbiology reporting is sequential because cultures mature over days:

A negative culture is also a final report ("no growth after X days"). Anaerobic and mycobacterial cultures need longer hold times before a true negative can be finalized -- finalizing a TB culture at 48 hours is wrong because growth can take weeks.

Selective Reporting and Antimicrobial Stewardship

Laboratories do not report every antibiotic tested. Cascade (selective) reporting releases narrow-spectrum first-line agents and suppresses broad-spectrum drugs unless the first-line drug is resistant. For example, a susceptible E. coli might report ampicillin and cephalexin while a broad carbapenem is suppressed -- this supports stewardship and reduces unnecessary broad-spectrum use. Suppressing drugs to which an organism is intrinsically resistant (e.g., a cephalosporin against Enterococcus) is also required so clinicians are not misled.

Public-Health Reportable Diseases

Certain organisms trigger mandatory notification to state/local public health regardless of the ordering clinician's wishes. High-yield reportable findings include Mycobacterium tuberculosis, Neisseria meningitidis, Salmonella/Shigella, Vibrio cholerae, Neisseria gonorrhoeae, and any suspected select agent. The MLS role is to flag the result through the laboratory's reporting workflow; failing to report a reportable communicable disease is both a quality and a legal lapse.

When a postanalytic item appears, identify whether it is a critical value, a stewardship/reporting rule, or a public-health duty, then choose the action the stem actually requires.

Result Verification, Correlation, and Error Correction

Before any microbiology result is released, the technologist performs result verification -- confirming the identification and susceptibility are internally consistent and biologically plausible. The exam tests "delta" and correlation checks adapted to microbiology: a susceptibility profile that contradicts the organism's known intrinsic resistance must be flagged before reporting. For example, an Enterococcus reported as cephalosporin-susceptible, or a Stenotrophomonas reported as carbapenem-susceptible, signals a setup or identification error, not a real finding.

Catching the contradiction is the best answer over simply releasing the panel.

Gram Stain and Culture Correlation

Gram stain results should correlate with culture growth. If the direct Gram stain of a wound showed abundant gram-positive cocci in clusters but the culture grew only gram-negative rods, the discrepancy must be investigated -- possible causes include a missed fastidious or anaerobic organism, antibiotic suppression of the cluster organism, or a labeling/processing error. The exam expects the technologist to reconcile the smear with the plate rather than ignore one of them.

Reporting Format and Amended Reports

Proper reporting language matters and is testable:

• Report quantity when clinically meaningful (e.g., urine colony counts as CFU/mL; light/moderate/heavy growth).
• Use approved nomenclature and avoid ambiguous abbreviations.
• A negative culture is reported as "no growth after [X] days" with the appropriate incubation period for the organism class.
• An amended/corrected report must be issued when an error is found after release, with the original result retained for the audit trail -- you never silently overwrite a released result.

Turnaround Time and Stewardship Linkage

Faster accurate reporting changes therapy, so the exam connects postanalytic speed to outcomes. A preliminary Gram stain reported within an hour lets clinicians start empiric therapy; a rapid molecular blood-culture panel that reports organism and key resistance genes within hours shortens time to optimal therapy and is a major stewardship lever. A worked scenario: a blood culture flags positive at 2 a.m., the Gram stain shows gram-positive cocci in clusters, and a rapid mecA result is positive.

The correct postanalytic actions are an immediate critical-value call, a preliminary report of presumptive MRSA, and documentation -- not waiting until the morning shift to release anything. Tie every postanalytic item to one question: does this result need to be verified, correlated, corrected, or urgently communicated, and to whom? Answer that, and the best option becomes clear, because microbiology reporting is judged by whether the right person can act on the result in time.